Bionexus Gene Lab CORP (BGLC) SEC Filings — 2024
21 SEC filings for Bionexus Gene Lab CORP (BGLC) in 2024.
Filings
- BioNexus Gene Lab Corp Files Q3 2024 10-Q — 10-Q · Nov 15, 2024
- BioNexus Gene Lab Corp. Faces Delisting Concerns — 8-K · Nov 8, 2024
- BioNexus Gene Lab Corp. Reports Board and Officer Changes — 8-K · Oct 15, 2024
- BioNexus Gene Lab Corp. Files 8-K on Corporate Matters — 8-K · Oct 10, 2024
- BioNexus Gene Lab Corp. Files 8-K for Material Agreement — 8-K · Sep 25, 2024
- BioNexus Gene Lab Corp Files 8-K — 8-K · Sep 18, 2024
- BioNexus Gene Lab Corp Files Definitive Proxy Statement — DEF 14A · Sep 16, 2024
- BioNexus Gene Lab Corp Files 8-K — 8-K · Sep 12, 2024
- BioNexus Gene Lab Corp. Files 8-K, Changes Fiscal Year — 8-K · Sep 5, 2024
- BioNexus Gene Lab Corp Files 8-K — 8-K · Aug 28, 2024
- BioNexus Gene Lab Corp. Enters Material Definitive Agreement — 8-K · Aug 26, 2024
- BioNexus Gene Lab Corp Files Q2 2024 10-Q — 10-Q · Aug 14, 2024
- BioNexus Gene Lab Corp Files 8-K/A Amendment — 8-K/A · Jul 5, 2024
- BioNexus Gene Lab Corp Files 2022 Annual Report Amendment — 10-K/A · May 31, 2024
- BioNexus Gene Lab Corp Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- BioNexus Gene Lab Corp. Faces Delisting Notice — 8-K · May 9, 2024
- BioNexus Gene Lab Corp Files 8-K — 8-K · Apr 18, 2024
- BioNexus Gene Lab Corp Files 2023 Annual Report on Form 10-K — 10-K · Apr 16, 2024
- BioNexus Gene Lab Corp. Files 8-K on Officer/Director Changes — 8-K · Apr 1, 2024
- BioNexus Gene Lab Corp Files 10-Q/A for Period Ending September 30, 2023 — 10-Q/A · Mar 26, 2024
- Insider Group Acquires 100% of BioNexus Gene Lab Corp. Shares — SC 13D · Jan 17, 2024